Macrosalb (Macrosalb (99mtc))

The active ingredient in Macrosalb is a radioactive isotope linked to a carrier molecule that targets specific tissues. After intravenous injection, the compound accumulates in the intended organ, and the emitted gamma photons are captured by imaging equipment, creating a visual map of tissue activity.

The dose of Macrosalb is determined by the prescribing physician based on the specific diagnostic procedure, patient weight, and clinical protocol. Only a qualified healthcare professional should calculate and administer the appropriate amount.

Macrosalb is generally avoided in pregnant or breastfeeding patients unless the diagnostic benefit clearly outweighs potential risks. The radiopharmaceutical can cross the placenta and may be excreted in breast milk, so clinicians must evaluate each case individually.

To order Macrosalb, submit an enquiry on the product page at gnhindia.com, specifying the required quantity. GNH India works with hospitals, pharmacies and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details (including cold‑chain if needed) and necessary import documentation.

Macrosalb offers a specific carrier‑isotope combination that may provide higher target specificity or improved image quality for certain organ systems compared with alternative tracers. Selection depends on the clinical indication, imaging equipment, and regulatory approvals in the treating region.

Macrosalb should be stored refrigerated at 2‑8 °C, protected from light, and never frozen or shaken. The kit must be kept in its original packaging until use, and handling should follow standard radiopharmacy safety procedures to prevent contamination and maintain product integrity.

Macrosalb is supplied as a kit for intravenous injection. After reconstitution according to the manufacturer’s instructions, the solution is administered by a qualified healthcare professional through a peripheral or central vein, typically immediately before the imaging study.

The most serious risks include severe allergic reactions such as anaphylaxis, significant hypotension, and radiation‑induced tissue injury. These events are rare but require prompt medical intervention and monitoring during and after the procedure.

Patients with known hypersensitivity to any component of the Macrosalb kit, pregnant women unless absolutely necessary, and individuals with severe renal impairment that could alter tracer clearance should avoid its use. Clinical judgment is essential to identify contraindications.